BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35967315)

  • 41. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.
    May MT; Gompels M; Delpech V; Porter K; Orkin C; Kegg S; Hay P; Johnson M; Palfreeman A; Gilson R; Chadwick D; Martin F; Hill T; Walsh J; Post F; Fisher M; Ainsworth J; Jose S; Leen C; Nelson M; Anderson J; Sabin C;
    AIDS; 2014 May; 28(8):1193-202. PubMed ID: 24556869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART.
    Gantner P; Pagliuzza A; Pardons M; Ramgopal M; Routy JP; Fromentin R; Chomont N
    Nat Commun; 2020 Aug; 11(1):4089. PubMed ID: 32796830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
    Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
    J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study.
    Watanabe D; Uehira T; Suzuki S; Matsumoto E; Ueji T; Hirota K; Minami R; Takahama S; Hayashi K; Sawamura M; Yamamoto M; Shirasaka T
    BMC Infect Dis; 2019 Jan; 19(1):11. PubMed ID: 30611204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.
    Vrisekoop N; van Gent R; de Boer AB; Otto SA; Borleffs JC; Steingrover R; Prins JM; Kuijpers TW; Wolfs TF; Geelen SP; Vulto I; Lansdorp P; Tesselaar K; Borghans JA; Miedema F
    J Immunol; 2008 Jul; 181(2):1573-81. PubMed ID: 18606713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replication.
    Worrell S; Deayton J; Hayes P; Emery VC; Gotch F; Gazzard B; Larsson-Sciard EL
    HIV Med; 2001 Jan; 2(1):11-9. PubMed ID: 11737371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites.
    Lee E; von Stockenstrom S; Morcilla V; Odevall L; Hiener B; Shao W; Hartogensis W; Bacchetti P; Milush J; Liegler T; Sinclair E; Hatano H; Hoh R; Somsouk M; Hunt P; Boritz E; Douek D; Fromentin R; Chomont N; Deeks SG; Hecht FM; Palmer S
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31723024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.
    Kekitiinwa A; Lee KJ; Walker AS; Maganda A; Doerholt K; Kitaka SB; Asiimwe A; Judd A; Musoke P; Gibb DM; ;
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):384-92. PubMed ID: 18931630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations between recent thymic emigrants and CD4+ T-cell recovery after short-term antiretroviral therapy initiation.
    Briceño O; Chávez-Torres M; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Pinto-Cardoso S; Reyes-Terán G
    AIDS; 2020 Mar; 34(4):501-511. PubMed ID: 31794524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The investigation of CD4+T-cell functions in primary HIV infection with antiretroviral therapy.
    Sun Y; Fu Y; Zhang Z; Tang T; Liu J; Ding H; Han X; Xu J; Chu Z; Shang H; Jiang Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7430. PubMed ID: 28700479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children.
    Mulu A; Liebert UG; Maier M
    BMC Infect Dis; 2014 Jan; 14():28. PubMed ID: 24422906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection.
    Singh AK; Salwe S; Padwal V; Velhal S; Sutar J; Bhowmick S; Mukherjee S; Nagar V; Patil P; Patel V
    Front Immunol; 2020; 11():182. PubMed ID: 32194543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment.
    Chehimi J; Azzoni L; Farabaugh M; Creer SA; Tomescu C; Hancock A; Mackiewicz A; D'Alessandro L; Ghanekar S; Foulkes AS; Mounzer K; Kostman J; Montaner LJ
    J Immunol; 2007 Aug; 179(4):2642-50. PubMed ID: 17675528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
    Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
    Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
    Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
    AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated CD57 and CD95 expressions are associated with lower numbers of CD4⁺ recent thymic emigrants in HIV-1 infected immune responders following antiretroviral treatment.
    Lu I; Eberhard J; Ahmad F; Bhatnagar N; Behrens G; Jacobs R; Schmidt RE; Meyer-Olson D
    Immunol Lett; 2014; 158(1-2):1-6. PubMed ID: 24291117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy.
    Resino S; Seoane E; Pérez A; Ruiz-Mateos E; Leal M; Muñoz-Fernández MA
    BMC Infect Dis; 2006 Jul; 6():112. PubMed ID: 16839416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4
    Real F; Capron C; Sennepin A; Arrigucci R; Zhu A; Sannier G; Zheng J; Xu L; Massé JM; Greffe S; Cazabat M; Donoso M; Delobel P; Izopet J; Eugenin E; Gennaro ML; Rouveix E; Cramer Bordé E; Bomsel M
    Sci Transl Med; 2020 Mar; 12(535):. PubMed ID: 32188724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection.
    Richardson MW; Sverstiuk A; Hendel H; Cheung TW; Zagury JF; Rappaport J
    Biomed Pharmacother; 2000 Feb; 54(1):21-31. PubMed ID: 10721459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.